Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bachur

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Molecular Pharmacology|November 1, 1984
Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analoguesP L Gutierrez, B M Fox, M M Mossoba, et al.
Molecular Pharmacology|November 1, 1993
Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator bindingN R Bachur, R Johnson, F Yu, et al.
Archives of Biochemistry and Biophysics|April 15, 1982
Radioimmunoassay and immunochemistry of Phaseolus vulgaris phytohemagglutinin: verification of isolectin subunit structuresR L Felsted, G Pokrywka, C Chen, et al.
Molecular Pharmacology|June 1, 1992
Helicase inhibition by anthracycline anticancer agentsN R Bachur, F Yu, R Johnson, et al.
Life Sciences|December 1, 1973
Cholesterol in cerebrospinal fluid of brain tumor patientsJ H Fleisher, L J Marton, N R Bachur, et al.
Molecular Pharmacology|July 1, 1979
Bleomycin A2: a ferrous oxidaseW J Caspary, C Niziak, D A Lanzo, et al.
Biochemical Pharmacology|May 1, 1985
Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical speciesP L Gutierrez, M J Egorin, B M Fox, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
The murine metabolism and disposition of marcellomycinP Dodion, M J Egorin, J M Tamburini, et al.
Biochimica Et Biophysica Acta|March 27, 1981
Phytohemagglutinin isolectin subunit compositionR L Felsted, R D Leavitt, C Chen, et al.
Investigational New Drugs|January 1, 1985
Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin)P Dodion, T A Davis, M Rozencweig, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Molecular Pharmacology|November 1, 1984
Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analoguesP L Gutierrez, B M Fox, M M Mossoba, et al.
Molecular Pharmacology|November 1, 1993
Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator bindingN R Bachur, R Johnson, F Yu, et al.
Archives of Biochemistry and Biophysics|April 15, 1982
Radioimmunoassay and immunochemistry of Phaseolus vulgaris phytohemagglutinin: verification of isolectin subunit structuresR L Felsted, G Pokrywka, C Chen, et al.
Molecular Pharmacology|June 1, 1992
Helicase inhibition by anthracycline anticancer agentsN R Bachur, F Yu, R Johnson, et al.
Life Sciences|December 1, 1973
Cholesterol in cerebrospinal fluid of brain tumor patientsJ H Fleisher, L J Marton, N R Bachur, et al.
Molecular Pharmacology|July 1, 1979
Bleomycin A2: a ferrous oxidaseW J Caspary, C Niziak, D A Lanzo, et al.
Biochemical Pharmacology|May 1, 1985
Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical speciesP L Gutierrez, M J Egorin, B M Fox, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
The murine metabolism and disposition of marcellomycinP Dodion, M J Egorin, J M Tamburini, et al.
Biochimica Et Biophysica Acta|March 27, 1981
Phytohemagglutinin isolectin subunit compositionR L Felsted, R D Leavitt, C Chen, et al.
Investigational New Drugs|January 1, 1985
Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin)P Dodion, T A Davis, M Rozencweig, et al.
Pageof 16